bucladesine has been researched along with Coronary Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daries, P; Lubbe, WF; Muller, C; Nathan, D; Opie, LH | 1 |
| Ban, M; Kanayama, H; Ogawa, K; Ukai, M | 1 |
| Ogawa, K; Ukai, M | 1 |
| Arentzen, CE; Backer, CL; Koumi, S; Sato, R | 1 |
| Hori, M; Inoue, M; Kamada, T; Kitabatake, A; Kitakaze, M; Sato, H; Takashima, S | 1 |
| Bast, A; Haenen, GR; Veerman, M | 1 |
| Böhm, M; Brown, L; Diet, F; Eichhorn, M; Erdmann, E; Kemkes, B; Näbauer, M; Pieske, B | 1 |
| Binz, KH; Flaig, W; Nennstiel, P; Podzuweit, T | 1 |
| Kane, KA; Morcillo-Sanchez, EJ; Parratt, JR; Rodger, IW; Shahid, M | 1 |
| Hakuta, T; Kaneko, Y; Kobayashi, K; Ohta, T; Sano, T; Yoshimura, H | 1 |
| Coetzee, WA; Opie, LH; Saman, S | 1 |
| Ban, T; Fujiwara, Y; Konishi, Y; Matsumoto, M; Nishimura, K; Nomoto, S; Okamoto, Y; Soneda, J | 1 |
| Gertler, MM; Guthrie, RG; Leetma, HE; Saluste, E; Starr, T | 1 |
13 other study(ies) available for bucladesine and Coronary Disease
| Article | Year |
|---|---|
Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Disease Models, Animal; Heart; Heart Ventricles; Myocardial Contraction; Potassium; Receptors, Adrenergic; Receptors, Adrenergic, beta; Swine; Theophylline | 1980 |
Myocardial norepinephrine and cyclic amp concentration following myocardial ischemia--relation to ventricular fibrillation and sudden death.
Topics: Animals; Bucladesine; Coronary Disease; Cyclic AMP; Death, Sudden; Dogs; Female; Male; Myocardial Infarction; Myocardium; Norepinephrine; Propranolol; Ventricular Fibrillation | 1983 |
Cyclic nucleotides concentrations in the canine heart with regional ischemia. The role of cyclic AMP in ventricular fibrillation and the effect of dibutyryl cyclic AMP.
Topics: Animals; Bucladesine; Coronary Disease; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dogs; Ligation; Myocardium; Ventricular Fibrillation | 1984 |
beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts.
Topics: Adrenergic beta-Agonists; Adult; Alkaline Phosphatase; Analysis of Variance; Barium; Bucladesine; Cardiomyopathy, Dilated; Cells, Cultured; Colforsin; Coronary Disease; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Female; Heart; Heart Failure; Heart Ventricles; Humans; Isoproterenol; Kinetics; Male; Membrane Potentials; Middle Aged; Myocardium; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Propranolol | 1995 |
Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs.
Topics: Adenosine; Animals; Blood Pressure; Bucladesine; Colforsin; Coronary Circulation; Coronary Disease; Dogs; Platelet Activation; Platelet Aggregation; Theophylline | 1991 |
Reduction of beta-adrenoceptor function by oxidative stress in the heart.
Topics: Adrenergic beta-Agonists; Animals; Benzene Derivatives; Bucladesine; Catecholamines; Cell Membrane; Colforsin; Coronary Disease; Free Radicals; Heart Atria; Heart Ventricles; Isoproterenol; Male; Rats; Rats, Inbred Strains; Terbutaline | 1990 |
Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Colforsin; Coronary Disease; Female; Histamine; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Papillary Muscles | 1988 |
The anti-arrhythmic effects of myocardial ischaemia. Relation to reperfusion arrhythmias?
Topics: Animals; Bucladesine; Cardiac Pacing, Artificial; Constriction; Coronary Disease; Coronary Vessels; Cyclic AMP; Heart Ventricles; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Swine; Tachycardia | 1989 |
The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat.
Topics: 1-Methyl-3-isobutylxanthine; Anesthesia; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Heart; Male; Myocardium; Quinazolines; Rats; Rats, Inbred Strains | 1985 |
[Effects of dibutyryl cyclic AMP on coronary flow and cardiac metabolism in ischemic heart disease].
Topics: Adult; Aged; Bucladesine; Coronary Circulation; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption | 1987 |
Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: significance for ischemic and reperfusion arrhythmias.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Electric Stimulation; Guinea Pigs; Heart; Hypoxia; Isoproterenol; Perfusion | 1988 |
[The effects of low-dose continuous infusion of dibutyryl cyclic AMP (DBcAMP)].
Topics: Adult; Aged; Blood Glucose; Bucladesine; Cardiac Output; Coronary Disease; Heart Rate; Hemodynamics; Humans; Middle Aged; Postoperative Period; Vascular Resistance | 1987 |
The use of cyclic AMP in ischemic vascular disorders.
Topics: Aged; Blood Glucose; Blood Platelets; Bucladesine; Coronary Disease; Cyclic AMP; Fatty Acids, Nonesterified; Female; Heart Failure; Humans; Insulin; Lactates | 1973 |